112 related articles for article (PubMed ID: 23465274)
21. PTEN mRNA expression is less pronounced in left- than right-sided colon cancer: a retrospective observational study.
Kuramochi H; Nakamura A; Nakajima G; Kaneko Y; Araida T; Yamamoto M; Hayashi K
BMC Cancer; 2016 Jun; 16():366. PubMed ID: 27296289
[TBL] [Abstract][Full Text] [Related]
22. High expression of AT-rich interactive domain 3A (ARID3A) is associated with good prognosis in colorectal carcinoma.
Song M; Kim H; Kim WK; Hong SP; Lee C; Kim H
Ann Surg Oncol; 2014 Dec; 21 Suppl 4():S481-9. PubMed ID: 24366420
[TBL] [Abstract][Full Text] [Related]
23. Rarity of PTEN deletions and EGFR amplification in malignant gliomas of childhood: results from the Children's Cancer Group 945 cohort.
Pollack IF; Hamilton RL; James CD; Finkelstein SD; Burnham J; Yates AJ; Holmes EJ; Zhou T; Finlay JL;
J Neurosurg; 2006 Nov; 105(5 Suppl):418-24. PubMed ID: 17328268
[TBL] [Abstract][Full Text] [Related]
24. PTEN genomic deletion is an early event associated with ERG gene rearrangements in prostate cancer.
Bismar TA; Yoshimoto M; Vollmer RT; Duan Q; Firszt M; Corcos J; Squire JA
BJU Int; 2011 Feb; 107(3):477-85. PubMed ID: 20590547
[TBL] [Abstract][Full Text] [Related]
25. Partial PTEN deletion is linked to poor prognosis in breast cancer.
Lebok P; Kopperschmidt V; Kluth M; Hube-Magg C; Özden C; B T; Hussein K; Mittenzwei A; Lebeau A; Witzel I; Wölber L; Mahner S; Jänicke F; Geist S; Paluchowski P; Wilke C; Heilenkötter U; Simon R; Sauter G; Terracciano L; Krech R; von d Assen A; Müller V; Burandt E
BMC Cancer; 2015 Dec; 15():963. PubMed ID: 26672755
[TBL] [Abstract][Full Text] [Related]
26. PIK3CA, BRAF, and PTEN status and benefit from cetuximab in the treatment of advanced colorectal cancer--results from NCIC CTG/AGITG CO.17.
Karapetis CS; Jonker D; Daneshmand M; Hanson JE; O'Callaghan CJ; Marginean C; Zalcberg JR; Simes J; Moore MJ; Tebbutt NC; Price TJ; Shapiro JD; Pavlakis N; Gibbs P; Van Hazel GA; Lee U; Haq R; Virk S; Tu D; Lorimer IA;
Clin Cancer Res; 2014 Feb; 20(3):744-53. PubMed ID: 24218517
[TBL] [Abstract][Full Text] [Related]
27. βIII-tubulin overexpression is an independent predictor of prostate cancer progression tightly linked to ERG fusion status and PTEN deletion.
Tsourlakis MC; Weigand P; Grupp K; Kluth M; Steurer S; Schlomm T; Graefen M; Huland H; Salomon G; Steuber T; Wilczak W; Sirma H; Simon R; Sauter G; Minner S; Quaas A
Am J Pathol; 2014 Mar; 184(3):609-17. PubMed ID: 24378408
[TBL] [Abstract][Full Text] [Related]
28. PTEN expression in renal cell carcinoma and oncocytoma and prognosis.
Hager M; Haufe H; Kemmerling R; Mikuz G; Kolbitsch C; Moser PL
Pathology; 2007 Oct; 39(5):482-5. PubMed ID: 17886097
[TBL] [Abstract][Full Text] [Related]
29. Analysis of PTEN gene by fluorescent in situ hybridization in renal cell carcinoma.
de Campos EC; da Fonseca FP; Zequ Sde C; Guimarães GC; Soares FA; Lopes A
Rev Col Bras Cir; 2013; 40(6):471-5. PubMed ID: 24573625
[TBL] [Abstract][Full Text] [Related]
30. Absence of MMP2 expression correlates with poor clinical outcomes in rectal cancer, and is distinct from MMP1-related outcomes in colon cancer.
Wong JC; Chan SK; Schaeffer DF; Sagaert X; Lim HJ; Kennecke H; Owen DA; Suh KW; Kim YB; Tai IT
Clin Cancer Res; 2011 Jun; 17(12):4167-76. PubMed ID: 21531813
[TBL] [Abstract][Full Text] [Related]
31. KRAS and BRAF mutations and PTEN expression do not predict efficacy of cetuximab-based chemoradiotherapy in locally advanced rectal cancer.
Erben P; Ströbel P; Horisberger K; Popa J; Bohn B; Hanfstein B; Kähler G; Kienle P; Post S; Wenz F; Hochhaus A; Hofheinz RD
Int J Radiat Oncol Biol Phys; 2011 Nov; 81(4):1032-8. PubMed ID: 20947270
[TBL] [Abstract][Full Text] [Related]
32. Predictors of cervical lymph node metastasis in salivary gland cancer.
Ettl T; Gosau M; Brockhoff G; Schwarz-Furlan S; Agaimy A; Reichert TE; Rohrmeier C; Zenk J; Iro H
Head Neck; 2014 Apr; 36(4):517-23. PubMed ID: 23780687
[TBL] [Abstract][Full Text] [Related]
33. A novel data-driven prognostic model for staging of colorectal cancer.
Manilich EA; Kiran RP; Radivoyevitch T; Lavery I; Fazio VW; Remzi FH
J Am Coll Surg; 2011 Nov; 213(5):579-588, 588.e1-2. PubMed ID: 21925905
[TBL] [Abstract][Full Text] [Related]
34. Epidermal growth factor receptor, phosphatidylinositol-3-kinase catalytic subunit/PTEN, and KRAS/NRAS/BRAF in primary resected esophageal adenocarcinomas: loss of PTEN is associated with worse clinical outcome.
Bettstetter M; Berezowska S; Keller G; Walch A; Feuchtinger A; Slotta-Huspenina J; Feith M; Drecoll E; Höfler H; Langer R
Hum Pathol; 2013 May; 44(5):829-36. PubMed ID: 23158210
[TBL] [Abstract][Full Text] [Related]
35. Insulin growth factor receptor-1 expression and loss of PTEN protein predict early recurrence in triple-negative breast cancer.
Iqbal J; Thike AA; Cheok PY; Tse GM; Tan PH
Histopathology; 2012 Oct; 61(4):652-9. PubMed ID: 22759273
[TBL] [Abstract][Full Text] [Related]
36. Homozygous 10q23/PTEN deletion and its impact on outcome in glioblastoma: a prospective translational study on a uniformly treated cohort of adult patients.
Srividya MR; Thota B; Shailaja BC; Arivazhagan A; Thennarasu K; Chandramouli BA; Hegde AS; Santosh V
Neuropathology; 2011 Aug; 31(4):376-83. PubMed ID: 21134002
[TBL] [Abstract][Full Text] [Related]
37. The differential impact of microsatellite instability as a marker of prognosis and tumour response between colon cancer and rectal cancer.
Hong SP; Min BS; Kim TI; Cheon JH; Kim NK; Kim H; Kim WH
Eur J Cancer; 2012 May; 48(8):1235-43. PubMed ID: 22071131
[TBL] [Abstract][Full Text] [Related]
38. Markers for EGFR pathway activation as predictor of outcome in metastatic colorectal cancer patients treated with or without cetuximab.
Tol J; Dijkstra JR; Klomp M; Teerenstra S; Dommerholt M; Vink-Börger ME; van Cleef PH; van Krieken JH; Punt CJ; Nagtegaal ID
Eur J Cancer; 2010 Jul; 46(11):1997-2009. PubMed ID: 20413299
[TBL] [Abstract][Full Text] [Related]
39. Array-based comparative genomic hybridization identifies CDK4 and FOXM1 alterations as independent predictors of survival in malignant peripheral nerve sheath tumor.
Yu J; Deshmukh H; Payton JE; Dunham C; Scheithauer BW; Tihan T; Prayson RA; Guha A; Bridge JA; Ferner RE; Lindberg GM; Gutmann RJ; Emnett RJ; Salavaggione L; Gutmann DH; Nagarajan R; Watson MA; Perry A
Clin Cancer Res; 2011 Apr; 17(7):1924-34. PubMed ID: 21325289
[TBL] [Abstract][Full Text] [Related]
40. Novel prognostic markers in the serum of patients with castration-resistant prostate cancer derived from quantitative analysis of the pten conditional knockout mouse proteome.
Kälin M; Cima I; Schiess R; Fankhauser N; Powles T; Wild P; Templeton A; Cerny T; Aebersold R; Krek W; Gillessen S
Eur Urol; 2011 Dec; 60(6):1235-43. PubMed ID: 21741162
[TBL] [Abstract][Full Text] [Related]
[Previous] [Next] [New Search]
